tech
Biotech Visionary Is Skeptical About AI’s Impact on Medical Innovation
The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human effort in the realm of scientific discovery, adding to a growing debate over its impact on medical research and innovation.
Read full story on Bloomberg Tech → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Tech alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop